JUDICIALIZAÇÃO DA SAÚDE SUPLEMENTAR NO CARIRI CEARENSE: UMA ANÁLISE JURIMÉTRICA DAS DECISÕES JUDICIAIS SOBRE A COBERTURA DE TRATAMENTO PARA CRIANÇAS E ADOLESCENTES AUTISTAS
JUDICIALIZATION OF SUPPLEMENTARY HEALTHCARE INCARIRI, CEARÁ: A JURIMETRIC ANALYSIS OF JUDICIALDECISIONS ON TREATMENT COVERAGE FOR AUTISTICCHILDREN AND ADOLESCENTS
DOI:
https://doi.org/10.56256/249m1874Abstract
The Autism Spectrum Disorder (ASD) is a neurodevelopmental condition that affects communication, behavior, and social interaction, and its increasing incidence has sparked significant discussions in social, political, and legal domains. The National Supplementary Health Agency (ANS) regulates mandatory treatment coverage, but several essential procedures for ASD are not included in its list. This study aims to analyze first-instance court decisions issued in the Cariri Cearense Districts (Crato and Juazeiro do Norte) between 2019 and 2024 through a quantitative approach and the use of jurimetric methodology. The research seeks to identify the main reasons for the acceptance or denial of treatment requests for ASD, investigating how the inclusion or exclusion of treatments in the ANS's mandatory coverage list impacts judicial decisions. Additionally, the study intends to examine which therapies and treatments generate the highest volume of litigation, as well as the success or failure rates for each type of demand. The research aims to provide data that can support improved litigation management, adaptation of demands, and the reduction of legal cases, promoting more effective and peaceful solutions to conflicts related to access to ASD treatment.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Ari Batista Macedo Costa, Álisson Melo

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
- Todos os artigos são publicados sob a licença Creative Commons - Atribuição Não Comercial (CC BY-NC), permitindo que terceiros copiem, distribuam e adaptem o conteúdo, desde que seja dada a devida atribuição ao autor e à revista.
- No caso da licença CC BY-NC, o uso comercial dos artigos não é permitido.










